​

Nurix Therapeutics (NRIX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Nurix Therapeutics Revenue Highlights

Latest Revenue (Y)

$83.98M

Latest Revenue (Q)

$7.89M

Main Segment (Y)

Collaboration Revenue

Nurix Therapeutics Revenue by Period

Nurix Therapeutics Revenue by Year

DateRevenueChange
2025-11-30$83.98M53.95%
2024-11-30$54.55M-29.15%
2023-11-30$76.99M99.31%
2022-11-30$38.63M29.84%
2021-11-30$29.75M66.95%
2020-11-30$17.82M-42.73%
2019-11-30$31.11M-16.91%
2018-11-30$37.45M-

Nurix Therapeutics generated $83.98M in revenue during NA 2025, up 53.95% compared to the previous quarter, and up 471.27% compared to the same period a year ago.

Nurix Therapeutics Revenue by Quarter

DateRevenueChange
2025-08-31$7.89M-82.08%
2025-05-31$44.06M138.75%
2025-02-28$18.45M38.91%
2024-11-30$13.28M5.53%
2024-08-31$12.59M4.10%
2024-05-31$12.09M-27.09%
2024-02-29$16.59M9.41%
2023-11-30$15.16M-17.91%
2023-08-31$18.47M-39.80%
2023-05-31$30.68M141.83%
2023-02-28$12.69M87.01%
2022-11-30$6.78M-37.14%
2022-08-31$10.79M-5.61%
2022-05-31$11.43M18.82%
2022-02-28$9.62M30.08%
2021-11-30$7.40M-27.86%
2021-08-31$10.25M44.58%
2021-05-31$7.09M41.51%
2021-02-28$5.01M-25.09%
2020-11-30$6.69M63.75%
2020-08-31$4.08M-2.32%
2020-05-31$4.18M46.02%
2020-02-29$2.86M53.81%
2019-11-30$1.86M-82.40%
2019-08-31$10.58M12.09%
2019-05-31$9.44M2.22%
2019-02-28$9.23M-

Nurix Therapeutics generated $7.89M in revenue during Q3 2025, up -82.08% compared to the previous quarter, and up 65.28% compared to the same period a year ago.

Nurix Therapeutics Revenue Breakdown

Nurix Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceNov 25Nov 24Nov 23
Collaboration Revenue$53.98M$54.55M$56.99M
License Revenue$30.00M$20.00M-

Nurix Therapeutics's latest annual revenue breakdown by segment (product or service), as of Nov 25: Collaboration Revenue (64.28%), and License Revenue (35.72%).

Quarterly Revenue by Product

Product/ServiceNov 25Aug 25May 25Nov 24Aug 24May 24Nov 23Aug 23May 23
License Revenue-$30.00M-------
Collaboration Revenue$32.03M$7.89M$14.06M$29.87M$12.59M$12.09M$27.84M$18.47M$10.68M

Nurix Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Nov 25: Collaboration Revenue (100.00%).

Nurix Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
FTREFortrea$2.72B$701.30M
PHATPhathom Pharmaceuticals$175.11M$49.50M
URGNUroGen Pharma$109.79M$27.48M
NRIXNurix Therapeutics$83.98M$7.89M
KURAKura Oncology$67.48M$20.75M
TNGXTango Therapeutics$62.38M$53.81M
SEPNSepterna$45.95M$21.50M
EYPTEyePoint Pharmaceuticals$31.37M$966.00K
KODKodiak Sciences--
BBOTBridgeBio Oncology Therapeutics--
XNCRXencor-$43.61M

NRIX Revenue FAQ

What is Nurix Therapeutics’s yearly revenue?

Nurix Therapeutics's yearly revenue for 2025 was $83.98M, representing an increase of 53.95% compared to 2024. The company's yearly revenue for 2024 was $54.55M, representing a decrease of -29.15% compared to 2023. NRIX's yearly revenue for 2023 was $76.99M, representing an increase of 99.31% compared to 2022.

What is Nurix Therapeutics’s quarterly revenue?

Nurix Therapeutics's quarterly revenue for Q3 2025 was $7.89M, a -82.08% decrease from the previous quarter (Q2 2025), and a -37.29% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $44.06M, a 138.75% increase from the previous quarter (Q1 2025), and a 264.34% increase year-over-year (Q2 2024). NRIX's quarterly revenue for Q1 2025 was $18.45M, a 38.91% increase from the previous quarter (Q4 2024), and a 11.26% increase year-over-year (Q1 2024).

What is Nurix Therapeutics’s revenue growth rate?

Nurix Therapeutics's revenue growth rate for the last 3 years (2023-2025) was 9.08%, and for the last 5 years (2021-2025) was 182.29%.

What are Nurix Therapeutics’s revenue streams?

Nurix Therapeutics's revenue streams in v 25 are Collaboration Revenue, and License Revenue. Collaboration Revenue generated $53.98M in revenue, accounting 64.28% of the company's total revenue, down -1.04% year-over-year. License Revenue generated $30M in revenue, accounting 35.72% of the company's total revenue, up 50.00% year-over-year.

What is Nurix Therapeutics’s main source of revenue?

For the fiscal year ending Nov 25, the largest source of revenue of Nurix Therapeutics was Collaboration Revenue. This segment made a revenue of $53.98M, representing 64.28% of the company's total revenue.